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Research
Ambient particulate matter (PM) exposure as a 
result of fossil combustion activity and vehicu-
lar traffic is associated with increased cardio-
respiratory morbidity and mortality (Delfino 
et al. 2005; Nel et al. 1998; Riedl 2008; Sun 
et al. 2005). This includes increased morbidity 
as a result of allergic disorders such as asthma 
and allergic rhinitis (Bernstein et al. 2004; 
D’Amato et al. 2005; Lippmann 2007). This 
is evidenced by epidemiologic studies demon-
strating an association between the incidence 
of allergic diseases and the residential freeway 
proximity as well as an increase in asthma 
flares after a sudden surge of ambient PM lev-
els (Bernstein et al. 2004; Samet et al. 2000). 
Although the acute asthma flares could relate 
to an exacerbation of existing airway inflam-
mation or airway hyperreactivity, PM could 
also exert an adjuvant effect in the respiratory 
tract that could lead to an increased prevalence 
of allergic disease (de Haar et al. 2006; Diaz-
Sanchez et al. 1997, 1999; Inoue et al. 2005; 
Kleinman et al. 2007; Matsumoto et al. 2006; 
Nel et al. 1998).
PM adjuvant effects have been dem-
onstrated in both animal and human stud-
ies (Diaz-Sanchez et al. 1997; Gilliland et al. 
2004; Kleinman et al. 2007; Matsumoto et al. 
2006; Steerenberg et al. 2003a, 2003b; Stevens 
et al. 2008; Whitekus et al. 2002). Although in 
humans it has been shown that intranasal instil-
lation of diesel exhaust particles (DEP) could 
enhance ragweed-induced immunoglobulin 
E (IgE) and interleukin-4 (IL-4) production, 
results from animal studies have demonstrated 
that low-dose challenge by aerosolized inhala-
tion or intratracheal instillation could enhance 
allergic sensitization to an experimental aller-
gen such as ovalbumin (OVA) (Diaz-Sanchez 
et al. 1997; Gilliland et al. 2004; Matsumoto 
et al. 2006; Steerenberg et al. 2003a, 2003b; 
Stevens et al. 2008; Whitekus et al. 2002). 
Similar findings in studies using ambient PM 
exposure, including the recent Los Angeles 
study, have demonstrated that the inhalation 
of concentrated ambient PM near a busy free-
way could increase antigen-induced airway 
responses in mice (Kleinman et al. 2007).
Two key issues regarding the adjuvant 
effect of PM are the mechanism of the adju-
vant effect and the PM components that are 
responsible for this effect. Although a variety 
of mechanisms have been shown to explain 
the adverse respiratory effects of PM, one pos-
sibility that has emerged is that the organic 
chemical fraction of PM could play an impor-
tant role in the adjuvant effect through the 
ability to generate reactive oxygen species 
(ROS) in the respiratory tract (Li et al. 2003a, 
2008; Nel et al. 2006). Organic DEP extracts 
are capable of changing the redox equilib-
rium of dendritic cells (DCs) in the mucosal 
immune system such that their ability to 
present OVA to T-cells results in a polarized 
immune response in which there is a decrease 
in T helper 1 (TH1) and increase in T helper 
2 (TH2) immunity (Chan et al. 2006). This 
leads to the prediction that the prooxidant 
potential of PM plays a role in determining 
adjuvant effect. This hypothesis has not yet 
been formally tested in an in vivo model for 
PM adjuvant effects. In fact, most of the ani-
mal studies to date have used poorly calculated 
PM doses that far exceed the real-life exposure 
amounts and do not address the mechanism of 
the adjuvant effect (Ichinose et al. 2004; Inoue 
et al. 2005; Steerenberg et al. 2003a, 2003b). 
Thus, we aimed to determine whether there 
is a positive correlation between the adjuvant 
effect of ambient concentrated PM and their 
content of redox cycling organic chemicals.
In this study, we used a murine intranasal 
sensitization model and a precise amount of 
size-fractionated ambient PM collected by par-
ticle concentrators in the Southern California 
Particle Center to determine how this concen-
trated PM may contribute to an adjuvant effect 
through intranasal administration in a murine 
OVA sensitization model (Li et al. 2003a). 
This model allowed us to compare ultrafine 
particles (UFPs) with an aerodynamic diameter 
< 0.15 µm with a mixed atmosphere of fine, 
< 2.5 µm particles, which in this report we 
refer to as fines and ultrafines (F/UF). The end 
points that we used to evaluate the adjuvant 
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Ba c k g r o u n d: It has been demonstrated that ambient particulate matter (PM) can act as an   adjuvant 
for allergic sensitization. Redox-active organic chemicals on the particle surface play an important 
role in PM adverse health effects and may determine the adjuvant effect of different particle types 
according to their potential to perturb redox equilibrium in the immune system. 
oBjectives: We determined whether the adjuvant effect of ambient fine particles versus ultrafine 
particles (UFPs) is correlated to their prooxidant potential. 
Me t h o d s : We have established an intranasal sensitization model that uses ambient PM as a poten-
tial adjuvant for sensitization to ovalbumin (OVA), which enhances the capacity for secondary OVA 
challenge to induce allergic airway inflammation. 
re s u l t s: UFPs with a greater polycyclic aromatic hydrocarbon (PAH) content and higher oxi-
dant potential enhanced OVA sensitization more readily than did fine particles. This manifests as 
enhanced allergic inflammation upon secondary OVA challenge, leading to eosinophilic inflam-
mation and mucoid hyperplasia starting at the nasal turbinates all the way down to the small 
pulmonary airways. The thiol antioxidant N-acetyl cysteine was able to suppress some of these 
sensitization events. 
co n c l u s i o n s: The adjuvant effects of ambient UFP is determined by their oxidant potential, which 
likely plays a role in changing the redox equilibrium in the mucosal immune system.
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effect of ambient PM included nasal and pul-
monary inflammation as the measurement of 
OVA-specific IgG1 and IgE in the blood. We 
also used morphometric analysis of mucosub-
stances and eosinophils to show that the allergic 
sensitization leads to an allergic inflammatory 
response in both upper and lower airways. 
Finally, we measured IL-5 and IL-13 produc-
tion as signature cytokines for TH2 allergic 
inflammatory responses. We found that the 
enhanced in vivo adjuvant effects of the con-
centrated ambient UFP correlate with a higher 
in vitro oxidant potential and higher content of 
redox-cycling organic chemicals.
Materials and Methods
Reagents. See Supplemental Material (avail-
able online at http://www.ehponline.org/
docs/2009/0800319/suppl.pdf) for information.
Ambient PM collection and endotoxin 
detection. We used the Versatile Aerosol 
Concentrator Enrichment System (VACES)
to collect ambient atmospheres composed of 
PM < 2.5 µm (fine/ultrafine; F/UF) as well 
as PM < 0.15 µm (ultrafine particles; UFPs) 
in downtown Los Angeles (Li et al. 2002a, 
2003b; Sioutas et al. 2005). The collection site 
was about 200 m from a major freeway, where 
most traffic consists of passenger cars and diesel 
trucks. The specific details about the charac-
teristics and composition of the PM collected 
near Interstate highway 110 has been previously 
reported (Sioutas et al. 2005). The particles 
were collected in sterile deionized water from 
10:00 hr to 17:00 hr Monday through Friday 
using an impinger (SKC West Inc., Fullerton, 
CA; Li et al. 2003b). The samples designated 
F/UF#1 and UF#1 were collected side by side 
in January 2007, and the collection of UF#2 
took place at the same site in September 2006. 
Although the F/UF atmosphere includes some 
UFPs, on a per mass basis the UFP atmosphere 
includes a much higher content of concentrated 
< 0.15 µm PM. Moreover, the UFP collec-
tions included PM with a much larger surface 
area and higher fractional organic carbon (OC) 
content than did the F/UF atmosphere (Araujo 
et al. 2008). All concentrated ambient particles 
(CAPs) contained low levels of endotoxin [see 
Supplemental Material, Table 1 (http://www.
ehponline.org/docs/2009/0800319/suppl.pdf)].
Allergic sensitization and PM exposure. We 
obtained 6- to 8-week-old female BALB/c mice 
from Charles River Laboratories (Hollister, 
CA). Mice were housed under standard labo-
ratory conditions approved by the University 
of California at Los Angeles (UCLA) Animal 
Research Committee. We used endotoxin-free 
OVA as the allergen for allergic sensitization. 
On day 1, mice in the PM exposure group 
received intranasal instillation of 0.5 µg of the 
PM suspension in a total volume of 50 µl. Mice 
in the OVA-only and control groups received 
the same volume of saline alone. On day 2, 
animals in the PM exposure groups received 
intranasal instillation of 0.5 µg PM together 
with 10 µg OVA, whereas those in the OVA 
and control groups received OVA and saline 
only. Intranasal instillations were repeated on 
days 4, 7, and 9. In a different experiment, we 
administered the thiol antioxidant N-acetyl 
cysteine (NAC) at a dose of 320 mg/kg through 
intraperitoneal injection 4 hr before each of the 
intranasal instillations on days 1, 2, 4, 7, and 
9. We have previously demonstrated the anti-
oxidant properties of this agent in animal and 
in vitro studies (Whitekus et al. 2002). After 
animals were rested, we then challenged them 
with 1% OVA aerosol for 30 min in a nebulizer 
on days 21 and 22 (Hao et al. 2003), and sacri-
ficed them on day 23. All animal procedures 
were approved by the UCLA Animal Research 
Committee. All mice were treated humanely, 
with regard for pain and suffering, by strictly 
following the guidelines set by UCLA and 
National Institutes of Health.
Animal necropsy, sample collection, and 
analysis. Mice were anesthetized by intra-
peritoneal injection of pentobarbital. We 
performed blood and bronchoalveolar lavage 
(BAL) collections and differential BAL cell 
counts as previously described (Hao et al. 
2003). The right lung was collected and stored 
in liquid nitrogen for future analyses. The left 
lung was expanded with 10% buffered forma-
lin before processing it for histologic staining 
and microscopy. We measured plasma OVA-
specific IgG1 (OVA-IgG1) and IgE (OVA-
IgE) by enzyme-linked immunosorbent assay 
(ELISA) (Hao et al. 2003). Quantification 
of nine proinflammatory cytokines [tumor 
necrosis factor-α (TNF-α), interferon-γ 
(IFN-γ), IL-4, IL-5, IL-6, IL-13, keratinocytes 
chemoattractant (KC), monocyte chemotactic 
protein-1 (MCP-1), and macrophage inflam-
matory protein 1 (MIP-1α)] in the BAL 
fluid was determined with the Cytometric 
Bead Array Mouse Inflammation Kit accord-
ing to the manufacturer’s instructions (BD 
BioSciences, San Diego, CA).
Nasal and lung tissue preparation for 
morphometry and immunohistochemis-
try. Tissues were removed from the nasal 
and intrapulmonary axial airway sections as 
shown in Supplemental Material, Figure 1 
(available online http://www.ehponline.org/
docs/2009/0800319/suppl.pdf). Nasal and 
lung tissues were prepared for morphometry 
and immunocytochemistry as described in 
detail in the Supplemental Material (avail-
able online at http://www.ehponline.org/
docs/2009/0800319/suppl.pdf).
Morphometric analysis of mucosubstances 
and eosinophils in nasal and pulmonary air-
ways. Quantitative analyses of stored muco-
substances and eosinophils in the surface 
epithelium lining of the maxilloturbinates in 
the proximal nasal section T1 and of the prox-
imal and distal axial airways in the lung (air-
way generations 5 and 11, respectively) were 
Table 1. Analyses of Pearson correlation coefficient.
  Pearson correlation 
Comparison  coefficient
OC vs. DTT  0.882
OC vs. HO-1a  0.943
Total PAH vs. DTT  0.967
Total PAH vs. HO-1a  0.997
aHO-1 band density was used to calculate the Pearson 
correlation coefficient.
Figure 1. The adjuvant effect of ambient UFP on allergic sensitization. (A) Ambient UFP (UF#1 and UF#2, 
0.5 µg/instillation) increased OVA-induced allergic inflammation in the lung. (B) Enhanced OVA-IgG1 produc-
tion by 0.5 µg UFP instillation. (C) Enhanced OVA-IgE production by 0.5 µg UFP instillation. (D) Administration 
of 0.1 µg of UFP enhanced OVA-IgG1 production in parallel with other effects on allergic sensitization. 
*p < 0.05 compared with control; #p < 0.05 compared with OVA alone.
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estimated using computerized image analy-
sis and standard morphometric techniques, 
as previously reported [see Supplemental 
Material, Figure 1 (http://www.ehponline.org/
docs/2009/0800319/suppl.pdf)] (Farraj et al. 
2003; Harkema et al. 1997). Supplemental 
Material (available online at http://www.
ehponline.org/docs/2009/0800319/suppl.
pdf) describes the methods in detail.
Induction of intracellular oxidative stress. 
We used heme oxygenase-1 (HO-1) protein 
expression in the murine macrophage cell line 
(RAW 264.7) as a biological oxidative stress 
marker that reflects the prooxidant poten-
tial of concentrated ambient PM (Li et al. 
2000, 2002a, 2003b). We performed Western 
blotting for HO-1 expression as previously 
described (Li et al. 2002a, 2002b, 2003b).
Dithiothreitol assay. We determined the 
abiotic assessment of the oxidant potential 
of CAPs by the dithiothreitol (DTT) assay. 
This assay quantitatively measures superoxide 
production by redox cycling organic chemicals 
such as quinones (Cho et al. 2005; Li et al. 
2003b). We have also previously shown that 
introducing fractionated organic DEP extracts 
into this assay demonstrates that most of the 
redox cycling activity resides in the polycy-
clic aromatic hydrocarbon (PAH)–enriched 
and quinine-enriched silica gel fractions 
(Li et al. 2000).
PM composition and chemical analysis. 
We used quartz and Teflon filters for CAP 
collection in parallel with the impinger sam-
ples. These filters were used to analyze PM 
chemical composition and PAH content as 
described in the Supplemental Material 
(available online at http://www.ehponline.
org/docs/2009/0800319/suppl.pdf) (Li et al. 
2003b).
Statistical analysis. We express results as 
mean ± SE. Differences among groups were 
evaluated by analysis of variance and the 
Student t-test was used to distinguish between 
pairs of groups. We considered p < 0.05 statis-
tically significant. Pearson correlation coeffi-
cients were calculated to examine associations 
between the oxidant potential and the chemi-
cal content of PM (Li et al. 2003b).
Results
Establishment of an allergic sensitization 
model to demonstrate the adjuvant effect of 
ambient UFP. Although most of the pub-
lished in vivo studies that have addressed the 
adjuvant effects of PM have used DEP, few 
have looked at ambient PM. We therefore 
set out to develop an animal model to test 
the adjuvant effect of ambient PM collected 
by particle concentrators in downtown Los 
Angeles. We collected two independent sets 
of ambient UFPs (UF#1 and UF#2) near 
Interstate highway 110 and used them in 
an OVA intranasal instillation model. In 
the initial setup, the mice received saline, 
OVA (10 µg), or OVA (10 µg) plus UFP 
(0.5 µg) for allergic sensitization. To exclude 
the possibility that the nanosized carbon 
core of the UFP was promoting the adjuvant 
effect, we also used an equivalent amount 
of ultrafine carbon black particles (CB) as 
a control. BAL analysis showed that both 
UF#1 and UF#2 were quite effective in 
enhancing OVA sensitization. Compared to 
saline, OVA alone, CB alone, or CB plus 
OVA, UFP plus OVA induced a statistically 
significant increase in the BAL eosinophil 
count (p < 0.05; Figure 1A). Extensive test-
ing of UFPs alone did not reveal an effect 
on eosinophilic inflammation. The enhanced 
airway inflammation was accompanied by 
significantly increased OVA-specific IgG1 
(OVA-IgG1) and IgE (OVA-IgE) in the 
plasma (Figure 1B, C). These Ig classes 
reflect TH2 immunity. Both UFP collections 
yielded similar results. CB alone or in com-
bination with OVA failed to exert an effect. 
Additional dose–response studies using UF#1 
showed that as little as 0.1 µg UFP could 
elicit an adjuvant effect as determined by the 
OVA-IgG1 response (Figure 1D).
We determined the extent of the allergic 
sensitization by nasal and pulmonary histo-
pathology and airway morphometry. Only 
mice exposed to the UFP/OVA combina-
tion exhibited allergic inflammation in the 
nasal mucosa (Figure 2A). These changes 
were restricted to intranasal regions lined 
by transitional or respiratory epithelium 
(Figure 2A). No changes occurred in the 
olfactory epithelium (data not shown). For 
a full account of the nasal sites that we ana-
lyzed, see Supplemental Material, Figure 2 
(available online at http://www.ehponline.
org/docs/2009/0800319/suppl.pdf). The 
principal pathologic changes were mucous cell 
metaplasia/hyperplasia of airway epithelium 
accompanied by a mixed inflammatory cell 
infiltration in the underlying lamina propria 
(Figure 2A) The infiltrates were composed 
of eosinophils, mononuclear cells (lympho-
cytes and plasma cells), and a lesser number 
of neutrophils. Figure 2A illustrates exposure-
related mucous cell metaplasia and eosinophil 
influx in the mucosa overlying the maxillo-
turbinates. In UFP-exposed mice, there was a 
markedly greater amount of mucosubstances 
in the nasal transitional epithelium lining the 
maxilloturbinates compared with those in the 
control or OVA-alone groups [Figure 2B; see 
Supplemental Material, Figures 1, 3 (http://
www.ehponline.org/docs/2009/0800319/
suppl.pdf)]. Morphometric determination 
of numeric cell density showed a significant 
increase of eosinophils at the nasal mucosa 
biopsy sites [Figure 2C; see Supplemental 
Material, Figures 1, 3 (http://www.ehponline.
org/docs/2009/0800319/suppl.pdf)].
The nasal mucosa and BAL changes 
were accompanied by histologic evidence of 
Figure 2. Histopathology and morphometry of nasal maxilloturbinates. Abbreviations: AB/PAS, Alcian 
blue–Periodic acid Schiff double stain; bv, blood vessel in subepithelial lamina propria; g, nasal lateral 
glands in lamina propria; H&E, hematoxylin and eosin stain; tb, turbinate bone. (A) Morphologic features 
of allergic rhinitis in OVA/UFP-exposed animals. Bars = 50 µm. Arrows in (E and F) depict AB/PAS-stained 
mucosubstances in airway eoithelium. Arrows in (I) depict eosinophils containing major basic protein. 
(B) Quantification of mucosubstances in the surface epithelium shown as volume density of intraepithelial 
mucosubstances (mean ± SE). (C) Numeric eosinophil densities in T1 nasal section. Bars represent group 
means (n = 4–6 mice) ± SE. 
*p ≤ 0.05 compared with saline or OVA alone.
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eosinophil and mononuclear cell infiltration 
around small airways in OVA/UFP-sensitized 
mice (Figure 3A). Similar to the changes in 
the nose, the major morphologic changes in 
the lungs of OVA/UF#1-treated mice con-
sisted of marked mucous cell metaplasia in the 
surface epithelium lining the conducting air-
ways (large- and small-diameter bronchioles) 
plus an associated mixed inflammatory cell 
influx consisting mainly of eosinophils, lym-
phocytes, and plasma cells in the interstitial 
tissues surrounding these airways (Figure 3A). 
Airway lesions were most severe in the main 
axial airways, but were also present to a 
slightly lesser degree in the small-diameter, 
terminal bronchioles of the mice exposed to 
both OVA and UFP. Along the axial airways, 
the volume densities of intraepithelial muco-
substances in the proximal and distal gen-
erations (5 and 11) were approximately 22 
and 24 times greater, respectively, than those 
measured at the same airway generations in 
saline-instilled control mice (Figure 3B).
Mice exposed to OVA only exhibited 
definitive but milder epithelial and inflamma-
tory alterations in the large-diameter, pretermi-
nal and small-diameter, terminal bronchioles 
(Figure 3). Moreover, the volume densities 
of mucosubstances in the proxi  mal axial air-
ways (generation 5) of OVA/UF#1-treated 
mice were approximately twice that of OVA-
treated mice (Figure 3B). In the distal axial 
airway (generation 11), OVA/UF#1-treated 
mice had almost five times more intraepithe-
lial mucosubstances compared with those in 
OVA-alone mice (Figure 3B). Consistent with 
allergic inflammation, morphometric analysis 
of numeric cell densities demonstrated a signifi-
cant increase of intramural eosinophils in both 
proximal and distal axial airways (Figure 3C).
UFP alone did not exert any effect in the 
lung. Figure 4 shows that, although 0.5 µg 
UF#1 alone had no impact, the same parti-
cle batch did exert an adjuvant effect when 
combined with OVA. This resulted in eosino-
philic inflammation and increased OVA-
specific IgG1 and IgE antibody production. We 
obtained similar results with UF#2 (Figure 1).
The adjuvant effect of UFP is related to 
their content of prooxidative organic chemicals. 
We have previously shown that combustion 
Figure 3. Histopathology and morphometry of the left lung lobe. Abbreviations: AB/PAS, Alcian blue–Periodic acid Schiff double stain; AL, airway lumen; ap, 
alveolar parenchyma; bv, blood vessel; e, airway surface epithelium. (A) Morphologic features of allergic lung inflammation in OVA/UFP-treated mice. Tissues 
from preterminal bronchioles were analyzed for mucosubstances in mucous cells and major basic protein in eosinophils. Bars = 50 µm. Asterisks depict peribron-
cholar mixed inflammatory cell infiltrate composed of lymphocytes, plasma cells and eosinophils. Arrows in (F) depict AB/PAS-stained mucosubstances in airway 
epithelium. Arrows in (I) depict eosinophils conatining major basic protein. (B) Quantification of mucosubstances in the surface epithelium lining the proximal and 
distal axial airways in the lung shown as volume density of intraepithelial mucosubstances (mean ± SE; n = 6/group). (C) Numeric densities of intramural eosino-
phils in the proximal and distal axial airways shown as group means ± SE (n = 4–6 mice). 
*p ≤ 0.05 compared with saline or OVA alone.
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Figure 4. UFP alone failed to elicit any proinflammatory effect. In the absence of OVA, intranasal instillation 
of UF#1 did not have any effect, whereas a combination of UF#1 and OVA induced significant increase in 
eosinophil infiltration (A) and OVA-specific IgG1 (B) and IgE production (C). 
*p < 0.05 compared with control. #p < 0.05 compared with OVA. 
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particles such as DEP have a high content of 
redox cycling organic chemicals in the PAH-
enriched aromatic and the quinone-enriched 
polar fractions (Li et al. 2000). Because UFPs 
mostly derive from combustion sources, 
these particles (UF#1 and UF#2) also exhibit 
high OC contents (47.3% and 64.6% on a 
per mass basis, respectively) compared with 
the mixed particle atmosphere (F/UF#1, 
18.9%; Figure 5A). Moreover, measure-
ment of the PAH content, which serves as a 
proxy for the presence of the redox cycling 
OC chemicals, showed that on a per mass 
basis the content of signature PAHs in the 
UFP is considerably higher than in the F/
UF#1 collection [Figure 5B; see Supplemental 
Material, Figure 3 (http://www.ehponline.
org/docs/2009/0800319/suppl.pdf)] (Araujo 
et al. 2008). The PAH profile is typical of 
combustion particles in which the partition-
ing of lower molecular weight PAHs is typi-
cal of a winter collection [see Supplemental 
Material, Figure 3 (http://www.ehponline.
org/docs/2009/0800319/suppl.pdf)] (Li et al. 
2002a). For instance, both UFP collections 
contained significantly larger amounts of 
PAHs such as benzo[a]pyrene (BaP) that can 
be metabolically converted to redox cycling 
quinones such as the benzo[a]pyrene quinones 
(BaP-Q). To determine whether the observed 
adjuvant effect can be correlated to differences 
in the oxidative stress potential of the UFP 
and < 2.5 µm collections, we performed abi-
otic and biotic assays that reflect their oxidant 
potential (Li et al. 2003b). HO-1 expression 
is a sensitive biotic assay for PM-induced oxi-
dative stress (Li et al. 2000, 2002a, 2002b, 
2003a, 2003b). Immunoblotting revealed that 
both UF#1 and UF#2 induced more robust 
HO-1 expression in the macrophage cell line 
RAW 264.7 compared with the F/UF#1 
(Figure 5C). We based the abiotic assay 
on the oxidation of DTT by redox cycling 
organic chemical compounds such as quino-
nes (Cho et al. 2005; Li et al. 2003b). This 
assay demonstrated that the DTT consump-
tion of UF#1 and #2 was > 2-fold higher than 
F/UF#1 (Figure 5D, p < 0.05). Calculation of 
the Pearson correlation coefficient confirmed 
that the higher PAH content of UFP correlates 
with HO-1 and DTT results (Figure 5B–D, 
Table 1). Although similar analyses could not 
be carried out in live animals in the early stage 
of the experiment, we have previously dem-
onstrated that DEP induce oxidative stress 
in mouse lungs as determined by a carbonyl 
protein assay (Whitekus et al. 2002).
UF#1 differed significantly from F/UF#1 
in its adjuvant effects in our intransal sen-
sitization model (Figure 6). Although the 
< 2.5 µm PM (F/UF#1) failed to significantly 
boost eosinophilic inflammation or OVA-
IgE and IgG1 responses, the UFP-only col-
lection (UF#1) was associated with significant 
adjuvant effects (Figure 6A–C). Similar adju-
vant effects could not be achieved by com-
bining OVA with endotoxin at levels similar 
to those present in ambient PM (Figure 6). 
For a discussion of endoxin levels of PM 
and OVA see Supplemental Material (avail-
able online at http://www.ehponline.org/
docs/2009/0800319/suppl.pdf).
Figure 5. Correlation between the organic chemical content of UFP and its oxidant potential. (A) Chemical 
analysis of UFP and < 0.25 µm collection. EC, elemental carbon. (B) Total content of 17 signature PAHs in UFP 
and F/UF collection. (C) Biotic assay showing HO-1 expression in RAW 264.7 cells as determined by immuno-
blotting. (D) Abiotic measurement by DTT assay to compare the redox potential of UFP and < 0.25 µm collection. 
*p < 0.05 compared with F/UF#1.
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Figure 6. The adjuvant effect is a unique feature of UFP. Ambient fine PM and UFP were simultaneously col-
lected and tested for their adjuvant effects. Although UFP reproduced previous results, F/UF had no effect. 
(A) BAL analysis showing the enhancing effect of UFP on eosinphilic inflammation in the lung. (B) Increased 
OVA-IgG1 production by UFP. (C) Increased OVA-IgE production by UFP. 
*p < 0.01 compared with control; #p < 0.01 compared with OVA alone or F/UF#1+OVA. 
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Analysis of proinflammatory cytokines and 
chemokines in the BAL fluid provided fur-
ther evidence of UFP adjuvant effects in vivo 
(Table 2). Although F/UF#1 had little effect, 
UF#1 significantly enhanced the induction 
of TH2 cytokines (IL-5 and IL-13) as well 
as several other proinflammatory mediators 
(TNF-α, IL-6, KC, MCP-1, and MIP-1α) 
on OVA challenge (Table 2). Endotoxin had 
no impact. Interestingly, the TH1 cytokine 
IFN-γ did not change in any of the groups 
(Table 2).
Use of a thiol antioxidant to suppress the 
adjuvant effect of UFP. We have previously 
demonstrated that thiol antioxidant NAC is 
effective in suppressing the adjuvant effect of 
DEP in vivo (Whitekus et al. 2002). NAC 
accomplishes this effect by serving as a gluta-
thione precursor and oxygen radical scavenger 
and through direct covalent coupling to redox 
cycling organic chemicals such as quinones 
(Xiao et al. 2003). Intraperitoneal administra-
tion of this agent 4 hr before the intranasal 
administration of UFP (days 1, 2 4, 7, and 9) 
significantly suppressed BAL eosinophils and 
OVA-specific IgG1 production (Figure 7A, 
B) but did not interfere with the OVA-IgE 
response (Figure 7C). The reason for this lack 
of the IgE response is unknown. We repeated 
the experiment, with the same result.
Discussion
There is growing recognition that the redox 
chemistry of organic chemical compounds 
plays a crucial role in the biological effect of 
ambient PM (Araujo et al. 2008; Dellinger 
et al. 2001; Li et al. 2003a, 2003b, 2008; Nel 
et al. 2001; Squadrito et al. 2001). Moreover, 
increased polar resolution of silica gel col-
umns that were prior loaded with an organic 
DEP extract has shown that most of the redox 
cycling activity in the OC fraction segregates 
with the PAH-enriched aromatic as well as 
the quinone-enriched polar fractions (Li et al. 
2000). Although a number of animal mod-
els have been established to study the adju-
vant effect of DEP on allergic sensitization, 
there are few data for ambient PM (Ichinose 
et al. 2004; Kleinman et al. 2007; Matsumoto 
et al. 2006; Samuelsen et al. 2008; Song et al. 
2008). In addition, previously published 
animals models for evaluating PM adjuvant 
effects have limitations in sensitivity, repro-
ducibility, and in vivo dosimetry. Here we 
show that ambient UFP collected by a parti-
cle concentrator act as an adjuvant for allergic 
sensitization. Moreover, the adjuvant effects 
were closely correlated to the higher oxi-
dant potential of UFP and could be partially 
blocked by NAC administration. We dem-
onstrate that the allergic sensitization by UFP 
leads to extensive excitation of allergic inflam-
mation in the upper as well as lower respira-
tory tract upon secondary OVA challenge. 
This presents another unique feature of our 
study. This allergy model could be useful for 
comparing ambient PM that varies in oxi-
dant potential as a result of differences in the 
source, collection site, season, and ambient 
temperature. In this regard, we have previ-
ously demonstrated that the oxidant potential 
of UFP varies with season and temperature, 
likely as a result of influencing the partition-
ing of redox cycling PAHs onto the particle 
surface (Li et al. 2002a).
We developed a murine model in which 
nanogram quantities of ambient UFP can 
be used to achieve allergic sensitization. 
Intranasal instillation with as little as 100–
500 ng UFP is sufficient to enhance allergic 
sensitization to OVA (Figure 1D). This aller-
gic sensitization manifested as significantly 
increased eosinophilic airway inflammation in 
parallel with increased OVA-IgG1 and OVA-
IgE production (Figure 1A–C). We could not 
elicit similar responses with the same dose of 
< 2.5 µm PM (F/UF#1; Figure 6). Although 
the latter collection includes some UFPs, 
the fractional composition is very different 
from the UFP collection (Figure 5) (Li et al. 
2002a). Although as much as 65% of the UFP 
weight derives from OC compounds, the OC 
content of the mixed atmosphere is much 
smaller (Figure 5). These differences reflect 
the higher content of UFPs in the < 0.15 µm 
atmosphere. From a toxicologic perspective, 
this could mean the redox active organic com-
pounds on the smaller particles could be more 
bioavailable because of their large surface area. 
We propose that PAHs are a good proxy for 
the specific redox cycling chemicals in the 
OC fraction that is responsible for the bio-
logical effect (Li et al. 2000, 2003a, 2003b; 
Nel et al. 1998; Stevens et al. 2008). This also 
agrees with the excellent correlation between 
the PAH content of UFP and their ability to 
induce DTT consumption and HO-1 expres-
sion (Figure 5, Table 1). PAHs such as BaP 
can be metabolically converted to BaP-Q, a 
series of potent redox cycling quinones that 
are responsible for oxidative stress (Li et al. 
2000; Mass and Kaufman 1979). In fact, BaP 
Table 2. The effects of UFP on cytokine levels in the lung (mean ± SE).
Cytokine  Saline  OVA  Endo+OVA   UF#1+OVA   F/UF#1+OVA
TNF-α  1.63 ± 0.1  2.75 ± 0.2  3.08 ± 0.5  5.40 ± 0.5*  3.22 ± 0.6
IFN-γ  1.13 ± 0.0  1.13 ± 0.0  1.20 ± 0.1  1.48 ± 0.2  1.07 ± 0.2
IL-5  0.95 ± 0.6  1.98 ± 0.2  1.95 ± 0.7  13.5 ± 3.1*  2.78 ± 0.9
IL-4  0.00 ± 0.0  0.25 ± 0.3  0.00 ± 0.0  0.82 ± 0.4  0.00 ± 0.0
IL-13  1.25 ± 0.5  1.51 ± 0.6  1.77 ± 0.2  4.19 ± 0.8*  1.81 ± 0.2
KC  3.84 ± 0.3  8.17 ± 0.8  4.81 ± 0.8  12.8 ± 0.6*  5.51 ± 1.0
IL-6  0.56 ± 0.3  1.41 ± 0.1  1.34 ± 0.1  2.43 ± 0.3*  1.22 ± 0.3
MCP-1  0.00 ± 0.0  0.00 ± 0.0  0.00 ± 0.0  9.34 ± 3.2*  0.00 ± 0.0
MIP1-α  1.09 ± 0.4  1.99 ± 0.1  2.56 ± 0.4  4.25 ± 0.6*  2.18 ± 0.3
Endo, endotoxin. The amount of endotoxin was equal to that in the PM samples.
BAL fluid was obtained from the same mice as those in Figure 6. All cytokine concentrations were in picograms per milliliter.
*p < 0.05 compared with control and OVA.
Figure 7. Partial inhibition of the UFP adjuvant effect by the thiol antioxidant NAC. (A) Pretreatment with 
NAC suppressed UFP-enhanced eosinophilia in the lung. (B) Inhibition of the UFP effect as determined by 
OVA-IgG1 production. (C) NAC failed to inhibit UFP-stimulated OVA-IgE production. 
#p < 0.05 compared with control. *p < 0.05 compared with OVA alone or UF#1+OVA+NAC. 
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has been shown to act as an adjuvant for aller-
gic sensitization in animal studies (Kadkhoda 
et al. 2004, 2005). CB, which lacks redox 
cycling compounds and consists mostly of 
elemental carbons, did not exert an adjuvant 
effect (Figure 1).
Organic chemical compounds such as 
oxy-PAHs and quinones are relevant organic 
chemical species in terms of PM redox chemis-
try and ROS generation (Bonvallot et al. 2001; 
Cho et al. 2005; Kumagai et al. 1997; Monks 
et al. 1992; Penning et al. 1999). A recent 
study has demonstrated that PAH coated onto 
PM2.5 could induce gene expression of cyto-
chrome P450 (CYP) 1A1, CYP2E1, NADPH 
quinone oxydo-reductase-1, and glutathione 
S-transferase-pi 1 and mu 3 in human alveo-
lar macrophages, suggesting the formation of 
biologically reactive metabolites and the role 
of carbonaceous core of PM as a physical car-
rier (Saint-Georges et al. 2008). Quinones 
act as catalysts that produce ROS and may 
be key compounds in PM toxicity along with 
transition metals. Quinones can be formed as 
by-products of diesel fuel combustion as well 
as from metabolic conversion of PAH in the 
lung (Bonvallot et al. 2001; Cho et al. 2005; 
Kumagai et al. 1997; Monks et al. 1992; 
Penning et al. 1999). Although the < 2.5 µm 
collection (F/UF#1) contained UFPs and 
redox-active chemicals, the lower PAH content 
and ability to promote oxidative stress effects 
could explain its lack of an adjuvant effect 
(Li et al. 2003a, 2003b; Xiao et al. 2003). 
These particles cannot induce the equivalent 
of a tier 1 oxidant response in our hierarchi-
cal oxidative stress model (Wang et al. 2005; 
Xia et al. 2004; Xiao et al. 2003). That level of 
oxidative stress, however, is mostly a protective 
response that is mediated by phase 2 enzyme 
expression and does not amount to the induc-
tion of proinflammatory effects (tier 2) that 
we postulate is required to modify the effect of 
antigen presentation in vivo so as to skew the 
immune response to TH2 cytokine production 
(Chan et al. 2006). In contrast, UFPs do have 
the ability to achieve this adjuvant threshold. 
We propose that a similar threshold is required 
for existing in vivo PM effects. Although the 
tenets of the hierarchical oxidative stress model 
still needs to be confirmed in vivo, the bio-
logical significance of oxidative stress in PM 
adjuvant effects was previously confirmed by 
the use of NAC (Li et al. 2002b; Whitekus 
et al. 2002). We further confirmed this in the 
present study by demonstrating that NAC was 
able to suppress eosinophilic inflammation 
and OVA-IgG1 production (Figure 6).
The physical and chemical properties of 
UFP play important roles in particle deposi-
tion in the respiratory system and transloca-
tion to the extrapulmonary tissues (BeruBe 
et al. 2007; Kreyling et al. 2006; Oberdorster 
2001; Peters et al. 2006). The small size and 
large surface area of these particles may con-
tribute in an important way to their adju-
vant effects. Their small size allows UFP to 
penetrate deeply into the lung and to enter 
epithelial and antigen-presenting cells, which 
could be responsible for promoting the adju-
vant effect (Chan et al. 2006; Li et al. 2002b, 
2003a, 2003b, 2008). The large surface area 
of UFP allows these particles to carry twice 
the cargo of organic chemical compounds, 
which we show are responsible for inducing 
oxidative stress responses. Thus, UFP likely 
carry a higher content of bioavailable redox-
active compounds on a per mass basis than do 
the larger particles (Araujo et al. 2008).
Little is known about the immunologic 
basis for PM adjuvant effects. Prooxidative 
PM can skew the immune response toward 
TH2 differentiation through an impact on 
DC signaling pathways (Porter et al. 2007). 
One explanation is that PM enhance DC 
antigen uptake and costimulatory receptor 
expression, leading to increased IL-13 and 
decreased IFN-γ production in T-cells (Porter 
et al. 2007). This is in keeping with the dem-
onstration of an increased IL-5 and IL-13 
content in BAL fluid of animals sensitized 
with OVA plus UFP (Table 2). Another 
possibility is that the generation of oxida-
tive stress by organic PM chemicals induce 
Nrf2 expression, which interferes in IL-12 
and IFN-γ production, thereby leading to 
decreased TH1 responses (Chan et al. 2006). 
Similar inhibitory effects on IFN-γ produc-
tion have also been demonstrated in intact 
animals (Finkelman et al. 2004).
In summary, we have established a highly 
sensitive in vivo model system for studying 
the adjuvant effect of ambient PM on allergic 
sensitization. This model demonstrates that 
ambient UFPs, but not F/UF, can act as an 
adjuvant to promote TH2 polarization and to 
enhance allergic sensitization. The adjuvant 
effect of UFP is premised on redox chemistry, 
which is closely related to the prooxidative 
organic chemical content on these particles.
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